DBV Technologies To Participate At Upcoming Investor Conferences - NewsBreak

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that DBV Technologies' senior management team will participate in upcoming virtual investor conferences in September. Goldman Sachs Eleventh Annual Biotech Symposium Company management will participate in virtual investor meetings on September 7,...